Moderna Inc said on Monday its experimental vaccine was 94.5per cent effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.
Moderna trial success gives world more hope in race to end pandemic
